OWA
ABBV icon

One Wealth Advisors’s AbbVie ABBV Stock Holding History

One Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$653K Buy
2,596
+714
+38% +$154K 0.07% 141
2026
Q1 		$409K Buy
1,882
+14
+0.7% +$3.11K 0.05% 197
2025
Q4 		$427K Sell
1,868
-273
-13% -$62.2K 0.05% 192
2025
Q3 		$496K Sell
2,141
-634
-23% -$129K 0.06% 164
2025
Q2 		$515K Sell
2,775
-663
-19% -$123K 0.07% 151
2025
Q1 		$720K Buy
3,438
+1,060
+45% +$206K 0.11% 113
2024
Q4 		$423K Buy
2,378
+1,005
+73% +$185K 0.06% 143
2024
Q3 		$271K Buy
1,373
+5
+0.4% +$933 0.04% 213
2024
Q2 		$262K Buy
+1,368
New +$227K 0.06% 175
2023
Q2 		– Sell
-2,371
Closed -$378K – 209
2023
Q1 		$378K Sell
2,371
-259
-10% -$39.6K 0.09% 126
2022
Q4 		$425K Sell
2,630
-220
-8% -$33.7K 0.1% 109
2022
Q3 		$382K Buy
2,850
+1,184
+71% +$170K 0.13% 97
2022
Q2 		$255K Buy
1,666
+51
+3% +$7.79K 0.07% 156
2022
Q1 		$262K Buy
+1,615
New +$235K 0.06% 167
2020
Q2 		– Sell
-3,696
Closed -$282K – 84
2020
Q1 		$282K Sell
3,696
-2,928
-44% -$249K 0.28% 56
2019
Q4 		$587K Buy
6,624
+1,487
+29% +$123K 0.43% 28
2019
Q3 		$389K Sell
5,137
-951
-16% -$65.2K 0.34% 42
2019
Q2 		$443K Sell
6,088
-239
-4% -$18.8K 0.37% 43
2019
Q1 		$510K Sell
6,327
-195,777
-97% -$16M 0.42% 32
2018
Q4 		$758K Buy
202,104
+199,979
+9,411% +$17.6M 0.75% 13
2018
Q3 		$201K Buy
+2,125
New +$202K 0.15% 121
2018
Q1 		– Sell
-1,894
Closed -$183K – 510
2017
Q4 		$183K Buy
+1,894
New +$179K 0.15% 121

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

One Wealth Advisors's ABBV Position: Q2 2026 in Review

One Wealth Advisors increased its AbbVie (ABBV) stake by 38% in Q2 2026, buying an estimated $154K and bringing the position to 2,596 shares worth $653K. The position accounts for 0.07% of the portfolio, ranked #141.

One Wealth Advisors first reported a position in ABBV in Q4 2017 and has held it in 22 quarters since. The position peaked at $758K in Q4 2018. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • One Wealth Advisors held 2,596 shares of AbbVie worth $653K as of Q2 2026.
  • One Wealth Advisors bought 714 AbbVie shares in Q2 2026, an estimated $154K.
  • AbbVie made up 0.07% of One Wealth Advisors's portfolio in Q2 2026, its #141 holding.
  • One Wealth Advisors first reported a position in AbbVie in Q4 2017 and has held it in 22 quarters since.
  • One Wealth Advisors's AbbVie position peaked at $758K in Q4 2018.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on One Wealth Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.